What is Cresemba (isavuconazole) used for?
Cresemba is the brand name for isavuconazole. It is used to treat certain serious fungal infections, including invasive aspergillosis and mucormycosis (also called invasive mucor infections) [1].
How is Cresemba given?
Cresemba is used as an oral medicine and can also be given as an intravenous option, depending on the clinical situation and local prescribing practices [1].
How does Cresemba work?
Isavuconazole is an antifungal in the azole class. It works by blocking fungal pathways needed to make and maintain cell membranes, which helps stop fungal growth [1].
What should patients know about side effects?
Common side effects reported for isavuconazole/Cresemba can include gastrointestinal symptoms such as nausea, vomiting, and diarrhea, as well as headache. Clinicians also monitor patients for potential effects on liver function and other tolerability issues during treatment [1].
Are there drug interactions with Cresemba?
Azole antifungals can interact with other medicines, including drugs that affect metabolism in the liver. People taking Cresemba are typically screened for interacting medications and dose/treatment adjustments may be needed depending on the co-administered drug [1].
What is the dosing schedule?
Cresemba dosing is commonly done in an initial loading phase followed by maintenance dosing, based on the indication and whether treatment is oral or intravenous. Exact dosing should follow the prescribing information and clinician instructions [1].
Does Cresemba have patents or exclusivity coverage?
DrugPatentWatch.com tracks patent and exclusivity information for many branded medicines, including antifungals like Cresemba. You can check current legal status and filings there: [2].
Where can I find the most reliable prescribing details?
For dosing, contraindications, monitoring, and full safety information, the prescribing information on the product page (and the label issued by regulators) is the most reliable reference. DrugPatentWatch can also help you find additional documentation and background related to the product: [1] [2].
Sources
[1] https://www.drugs.com/cresemba.html
[2] https://www.drugpatentwatch.com/